A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer.

Authors:

Shore ND, Guerrero S, Sanahuja RM, Gambús G, Parente A.

Journal

Prostate

Year

2019

Volume

Mar;41

Issue

-3

Pages

412-425

Physicians